Urgent Procurement of the Drug FABHALTA (IPTACOPAN)

This tender, issued by the AZIENDA OSPEDALIERA UNIVERSITARIA DI PARMA, concerns the urgent supply of the pharmaceutical product FABHALTA (IPTACOPAN). The procurement was conducted through a negotiated procedure without prior tender publication, highlighting the urgent need for this medication. The location for this supply is PARMA. The estimated value and the award value are identical, at EUR 217,357.54, indicating a direct award to the specified supplier. The awardee for this urgent supply is NOVARTIS FARMA SPA. This procurement ensures that patients at the Parma University Hospital have timely access to essential medication.

This is a supplies contract in the general supplies sector, with a focus on General Supplies. Located in Italy, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 217,358.

Published through ANAC (Italy), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.